Maximal tumor debulking with systemic therapy does not affect QoL in mCRC
Colorectal cancer, medical illustration 3D illustration: © Anatomy Insider – Stock.adobe.com Results from ORCHESTRA’s prespecified exploratory analysis show that even the addition of maximal tumor debulking to standard systemic therapy is associated with lower risk of cancer in patients with metastatic colorectal cancer (mCRC) compared to systemic therapy alone. trial (NCT01792934) that had no significant […]
Study finds that tumor debulking does not affect quality of life in patients with metastatic colorectal cancer
New research in October 2023 issue JNCCN-;National Comprehensive Cancer Network Journal In addition to standard systemic therapy, intensive local treatment to remove as much tumor as possible (known as “debulking”) can have a significant impact on the overall quality of life of patients with metastatic colorectal cancer. I discovered that it doesn’t give. Researchers looked […]